Literature DB >> 1535613

Atrial natriuretic factor influences renal diurnal rhythm in essential hypertension.

W M Janssen1, D de Zeeuw, G K van der Hem, P E de Jong.   

Abstract

We investigated in six patients with essential hypertension the effect of a low dose atrial natriuretic factor infusion for 5 days on the diurnal rhythm of renal electrolyte excretion. Atrial natriuretic factor infusion increased the net excretion of sodium and caused a delay in its time of maximal diurnal urinary excretion. Similarly, atrial natriuretic factor caused an increase in the net excretion of chloride, calcium, and magnesium and also changed the diurnal rhythms of these electrolytes. In contrast, atrial natriuretic factor did not change the net excretion of potassium, phosphate, and uric acid, nor did atrial natriuretic factor change the diurnal rhythms of these solutes. During baseline, the time points of maximal urinary excretion of sodium and potassium overlapped, whereas atrial natriuretic factor infusion caused sodium excretion to peak 2.2 +/- 0.3 hours (p less than 0.02) after the potassium excretion peak. During baseline, the time of maximal urinary excretion of sodium did not correlate with the time of highest blood pressure, whereas it correlated negatively with mean plasma aldosterone concentration. In contrast, during atrial natriuretic factor infusion the time of maximal urinary excretion of sodium correlated positively with the time of highest blood pressure, whereas it did not correlate with mean plasma aldosterone concentration. These data suggest that atrial natriuretic factor is involved with the diurnal rhythm of the urinary excretion of sodium and that atrial natriuretic factor-induced natriuresis is mediated in part by blood pressure and plasma aldosterone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1535613     DOI: 10.1161/01.hyp.20.1.80

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  1 in total

1.  Role of atrial natriuretic peptide in the development of arterial hypertension in patients with pubertal hypothalamic syndrome.

Authors:  T P Krivchenko; N I Verbovaya
Journal:  Neurosci Behav Physiol       Date:  1998 Jul-Aug
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.